Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by R-pharm, explained in plain language.
This study compares a new experimental drug, RPH-030, to the approved drug Vectibix in people with metastatic colorectal cancer that has a specific gene type (wild-type RAS). About 180 participants will receive either RPH-030 or Vectibix along with standard chemotherapy (FOLFIRI)…
Phase: PHASE1 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC